Company Data

Panbela Therapeutics Inc.

Ticker
PBLA
Current Price
$0.2371 -3.39%
Market Cap
$1.2M
Price Target
Refer to Report
Volume
16.7K
52wk Range
$0.2344 - $0.4827
Advanced Market Data

Overview

Panbela Therapeutics Inc is a clinical stage drug development company. It is engaged in the commercial development of a proprietary polyamine analogue for pancreatic cancer and for the second indication in chronic pancreatitis. The firm has developed a polyamine analogue compound referred as SBP-101 for the exocrine pancreas, with therapeutic potential for both pancreatic cancer and pancreatitis indications.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy